Celldex Therapeutics (CLDX) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Celldex Therapeutics (CLDX) over the last 15 years, with Q3 2025 value amounting to 0.0.
- Celldex Therapeutics' Asset Utilization Ratio fell 6756.36% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 6756.36%. This contributed to the annual value of 0.01 for FY2024, which is 3365.08% down from last year.
- Per Celldex Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.0 for Q3 2025, which was down 6756.36% from 0.01 recorded in Q2 2025.
- Over the past 5 years, Celldex Therapeutics' Asset Utilization Ratio peaked at 0.04 during Q2 2021, and registered a low of 0.0 during Q2 2022.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.01 (2024), whereas its average is 0.01.
- Per our database at Business Quant, Celldex Therapeutics' Asset Utilization Ratio plummeted by 9510.29% in 2022 and then soared by 43949.11% in 2023.
- Quarter analysis of 5 years shows Celldex Therapeutics' Asset Utilization Ratio stood at 0.01 in 2021, then crashed by 36.5% to 0.01 in 2022, then skyrocketed by 182.66% to 0.02 in 2023, then plummeted by 52.91% to 0.01 in 2024, then plummeted by 55.38% to 0.0 in 2025.
- Its last three reported values are 0.0 in Q3 2025, 0.01 for Q2 2025, and 0.01 during Q1 2025.